Back to LH Stock Lookup
Pages: 1 2 »» Last Page

Lab Corp. (LH) – Press Releases

Nov 21, 2016 08:45 AM Computerworld Names Covance’s Dimitris Agrafiotis a Premier 100 Technology Leader
Nov 1, 2016 08:45 AM LabCorp is Scheduled to Present at the 2016 Credit Suisse Healthcare Conference
Oct 26, 2016 06:53 AM Laboratory Corporation of America® Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance
Oct 25, 2016 08:30 AM Covance Central Laboratory Services Ranks No. 1 in Global Investigator Satisfaction for the Third Consecutive Time
Oct 24, 2016 04:05 PM German Court Issues Preliminary Injunction Against amedes Fetalis® Test for Infringement of Non-Invasive Prenatal Screening Patent
Oct 24, 2016 07:00 AM LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche
Oct 20, 2016 07:00 AM Emulate Announces Strategic Collaboration with Covance to Integrate Organs-on-Chips Technology in Drug Evaluation
Oct 18, 2016 08:45 AM LabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
Oct 12, 2016 06:00 PM Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running
Oct 4, 2016 06:30 AM Shore Capital Partners Announces Sale of ClearPath Diagnostics
Oct 3, 2016 08:45 AM Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
Sep 30, 2016 08:45 AM LabCorp Subsidiary Sequenom, Inc. Announces Early Tender Results for Tender Offers and Successful Completion of Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior
Sep 20, 2016 08:30 AM LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development
Sep 16, 2016 02:00 PM LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
Sep 12, 2016 08:51 AM LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
Sep 7, 2016 08:58 AM Laboratory Corporation of America® Holdings Successfully Completes Acquisition of Sequenom, Inc.
Sep 6, 2016 08:45 AM LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
Aug 23, 2016 08:45 AM LabCorp’s Acquisition of Sequenom Clears Antitrust Review
Aug 9, 2016 08:00 AM LabCorp Commences Cash Tender Offer for All Outstanding Shares of Sequenom, Inc.
Aug 2, 2016 12:45 PM LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test
Jul 27, 2016 07:00 AM LabCorp Announces Agreement To Acquire Sequenom
Jul 27, 2016 06:59 AM LabCorp Announces Agreement to Acquire Sequenom
Jul 27, 2016 06:56 AM Laboratory Corporation of America® Holdings Announces 2016 Second Quarter Results and Raises 2016 Guidance
Jul 20, 2016 07:30 AM Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp
Jul 1, 2016 08:45 AM Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
Jun 27, 2016 08:45 AM LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer
Jun 8, 2016 04:15 PM LabCorp is Scheduled to Present at the 36th Annual William Blair Growth Stock Conference
Jun 6, 2016 08:45 AM LabCorp Announces the Availability of the RealStar® Zika Virus Test
Jun 1, 2016 08:11 AM One Year After Launch, BRCA Share™ Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
May 19, 2016 08:45 AM New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer
May 9, 2016 08:45 AM LabCorp Announces the Launch of the Epi proColon® Test for Colorectal Cancer Screening
May 6, 2016 08:45 AM LabCorp to Webcast Its Annual Meeting of Stockholders
Apr 25, 2016 06:51 AM Laboratory Corporation of America® Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance
Apr 11, 2016 08:45 AM LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization Services for Covance Drug Development
Apr 4, 2016 08:00 AM Conversion Right Triggered for Labcorp’s Zero Coupon Convertible Subordinated Notes Due 2021
Mar 21, 2016 08:45 AM LabCorp Completes Acquisition of Assets of Pathology, Inc.
Mar 14, 2016 08:45 AM Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials
Mar 11, 2016 08:00 AM LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
Mar 8, 2016 08:45 AM LabCorp is Scheduled to Present at the Barclays Capital 2016 Global Healthcare Conference
Mar 2, 2016 08:45 AM LabCorp is Scheduled to Present at the 37th Annual Raymond James Institutional Investors Conference
Feb 18, 2016 06:50 AM Laboratory Corporation of America® Holdings Announces 2015 Fourth Quarter and Full Year Results and Provides 2016 Guidance
Jan 27, 2016 05:08 PM LabCorp and Cheeriodicals Spread Cheer to UNC Children’s
Jan 12, 2016 06:30 AM Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Jan 7, 2016 08:45 AM LabCorp Announces New Board Member
Jan 6, 2016 08:15 AM LabCorp is Scheduled to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 4, 2016 04:15 PM Proprietary LabCorp Clinical Decision Support Report Improves Adherence to Chronic Kidney Disease Treatment Guidelines
Jan 4, 2016 08:45 AM Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
Dec 10, 2015 08:45 AM LabCorp Enters into Definitive Agreement to Acquire Assets of Pathology, Inc.
Nov 30, 2015 05:25 PM LabCorp Launches New Enhanced Report for Medical Drug Monitoring
Nov 3, 2015 08:45 AM LabCorp is Scheduled to Present at the 2015 Credit Suisse Healthcare Conference
Pages: 1 2 »» Last Page

Back to LH Stock Lookup